Navigation Links
Medical World Recognises New Therapy for Reflux Babies
Date:8/25/2009

NINOVE, Belgium, August 25 /PRNewswire/ -- 20% of parents seek medical help because of the frequent regurgitation (spitting up food) of their baby and the accompanying discomfort (crying). Reputed medical journal "Archives of Disease in Childhood" of the "British Medical Journal" group recently published the results of the clinical research project that began at the end of 2006 in the Children's gastroenterology department of the Brussels University Hospital.

The AR bed, a development of the MULTICARE Company and the Brussels University Hospital, was investigated in a group of babies that regurgitated and cried a lot, for who medication or adapted food hadn't helped. It was determined that the "AR bed" resulted in less regurgitation and crying in 3/4 of the babies. In addition, it was objectively established that the reflux index (% of time when there is acid in the oesophagus, measured with pH metry) almost halved within a week.

Taking account of the period of despair to desperation among parents and their baby, whether or not combined with various examinations (oesophagoscopy , pH metry, etc.), in their search for a suitable adaptation of food and medication, the AR bed[1] can offer comfort much sooner: in general, improvement is noticed within a day.

The AR bed is now suggested by paediatricians as a first step in the treatment of regurgitation and/or gastro-oesophageal reflux. Apart from reassuring parents, a nutritional approach (adapted volume, thickened Anti-Regurgitation food); this posture therapy contributes to the decrease of complaints. This is a major step forward in ending the spiral of medication overuse in babies who spit up food and cry a lot.

Professor Y. Vandenplas: "Medication is mainly of use in reflux disease, i.e. acid reflux and oesophagitis. Many babies who spit up food do not have reflux disease. In other words, medication has little use for these babies. All medication has potential side effects, which is why avoiding this medication is preferable. Experience with the MULTICARE AR bed has taught us that a fair number of children no longer needed to take medication."

More information can be found on http://www.multicare.be/eng/arbedeng.html

---------------------------------

[1] The MULTICARE AR bed is already available in Belgium through pharmacies (distributor Aprophar TGZ) and can be rented at a daily price of EUR1.75. Home delivery transport cost is EUR 12.10, disinfection + cleaning is EUR 15.00. Option to buy a sleeping bag: EUR 40.00.

The manufacturer, PEOS bvba, is looking for a UK-based distributor that is able to offer the general public the same service.


'/>"/>
SOURCE PEOS bvba
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016  EIP ... it has obtained proof-of-mechanism for neflamapimod (previously code ... completed Phase 2a clinical trials that demonstrated significant ... Study 302 (12-week treatment) and Study 303 (6-week ... Clinical Trials in Alzheimer,s Disease (CTAD) scientific conference ...
(Date:12/8/2016)... , Dec. 8, 2016 A Small ... the National Institutes of Health (NIH) to ... University.  The grant will seek to ... head device, which utilizes electromagnetic waves to treat Alzheimer,s ... this novel technology to possibly treat other neurologic disorders ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView Software aims ... employees that are both engaging and easy to use. Coming off the heels ... company revealed today its plans to roll out new AI-powered self-service enhancements to ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... Dallas, TX (PRWEB) , ... December 08, 2016 , ... ... to continue to be a convenient service for Texas, they are expanding their presence ... will involve a hiring spree that will bring new jobs to the Dallas and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):